The Drug Supply Chain Security Act (DSCSA) is a federal framework designed to protect patients by detecting and removing potentially dangerous, counterfeit, or contaminated drugs from the biological and pharmaceutical supply chain.

While the initial rollout and subsequent stabilization periods have concluded for manufacturers, distributors, and larger pharmacies, the final phase of implementation is rapidly approaching. On November 27, 2026, the final exemption window closes for small dispensers. Non-compliance after this absolute deadline can result in severe federal penalties, including fines, license suspension, or product seizures.

The Small Dispenser Exemption

Recognizing that community pharmacies and independent practices face unique operational hurdles, the FDA issued a blanket exemption giving smaller facilities an extended runway to build out their technology systems.

• The Criteria: An entity qualifies as a “small dispenser” if the parent corporate entity owns the dispenser and maintains a total of 25 or fewer full-time employees (licensed pharmacists or qualified pharmacy technicians) as of November 27, 2024.

• Automatic Relief: Unlike individual waiver requests, eligible small dispensers do not need to apply for this exemption. It is automatically active until November 27, 2026.

What are Small Dispensers Exempt From?

Until the exemption expires later this year, small dispensers are legally permitted to delay the implementation of Enhanced Drug Distribution Security requirements. Specifically, they are not yet mandated to use fully electronic, interoperable, package-level methods to:

• Exchange digital Transaction Information and Transaction Statements via secure GS1 EPCIS electronic files.
• Track and trace individual product transaction histories down to the specific package level during recalls.
• Instantly pull electronic tracking data to respond to a regulator or trading partner during an investigation.

 

“Exempt” Does Not Mean “Excused”

A common misconception is that small dispensers have a total pass on DSCSA until the deadline. This is incorrect. The exemption only applies to automated electronic data-interoperability (EDDS). Small dispensers are being actively audited right now and must continue to comply with all core DSCSA requirements:

• Authorized Trading Partners: You must only source prescription drugs from fully licensed, FDA-authorized manufacturers, repackagers, and wholesale distributors.
• Six-Year Record Keeping: You must accept, verify, and store paper or manual portal transaction data for every prescription drug received, retaining those records for 6 years.
• Verification and Quarantine: You must maintain strict Standard Operating Procedures (SOPs) to identify, quarantine, investigate, and notify the FDA if a suspect or illegitimate product is found in your inventory.

Managing Your GLNs

To successfully transition to fully electronic tracking by the end of this year, every physical location that receives or dispenses prescription products must be identified by a Global Location Number (GLN).

A GLN is a standardized 13-digit numeric code established by GS1 that acts as a digital fingerprint for your specific facility. Major wholesale distributors will completely block shipments and withhold necessary electronic data files (EPCIS) if a facility does not have a verified GLN attached to its account. Because GLNs are required for every individual physical shipping address under your corporate umbrella, keeping accurate track of these numbers is paramount to avoiding immediate distribution disruptions.

CHC’s Recommendations

We strongly recommend that all small dispensing facilities treat the remaining months of this year as an active implementation window rather than a waiting period.

1. Audit Your GLN Portfolio: Ensure every physical location in your network has an active, valid GLN. If you do not know your facility’s GLN, or are unsure if you need to register for a new one, reach out to the CHC team immediately so we can look up your credentials or request a GLN from HealthTrust on your behalf.
2. Map Out Your Tech Infrastructure: Work with your primary wholesale distributors now to test your electronic data pathways and ensure your portals are ready to receive data files linked to your GLN.
3. Audit Your Staffing Count: Ensure your corporate documentation proves you meet the 25-FTE threshold to confidently claim small dispenser status if questioned during a state board or federal inspection.
4. Update Internal SOPs: Ensure your pharmacy workflows are updated so staff can confidently flag, isolate, and log suspect products.